Summary
Using monoclonal antibodies three types of membrane-bound tumour-associated antigens have been identified on human melanoma cells. The tissue distribution, the immunological profile and the structural properties of these melanoma-associated antigens (MAA) are described. The applications of the monoclonal antibodies to one of the MAA in the area of immunodiagnosis and immunotherapy are discussed.
References
Accolla R. S., Carrel S., Mach J. P.: Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines — Proc. nat. Acad. Sci. (Wash.)77, 563, 1980.
Burchiel S. W., Imai K., Ferrone S., Warner N. L.: Heterogeneity of cell-surface antigenexpression expression of human melanoma cells: analysis with monoclonal antibodies and flow cytometry. In:Mitchell M., Oettgen H. (Eds): Hybridoma in cancer diagnosis and treatment. Raven Press, New York. (In press).
Bystryn J. C., Smalley J. R.: Identification and solubilization of iodinated cell surface human melanoma associated antigens — Int. J. Cancer20, 165, 1977.
Carrel S., Accolla R. S., Carmagnola A. L., Mach J. P.: Common melanoma associated antigen(s) detected by monoclonal antibodies — Cancer Res.40, 2523, 1980.
Colcher D., Horan Hand P., Nuti M., Schlom J.: A spectrum of monoclonal antibodies reactive with mammary tumor cells — Proc. nat. Acad. Sci. (Wash.)78, 3199, 1981.
Curry R., Quaranta V., Wilson B. S., McCabe R. P., Natali P. G., Pellegrino M. A., Ferrone S.: Expression of HLA antigens on cultured melanoma cells: lack of association with melanoma-associated antigens. In:Ferrone S., Gorini S., Herberman R. B., Reisfeld R. A. (Eds): Current trends in tumor immunology. Garland STPM Press, New York, 1979; p. 347.
Cuttitta F., Rosen S., Gazdar A. F., Minna J. D.: Monoclonal antibodies that demonstrate specificity for several types of human lung cancer — Proc. nat. Acad. Sci. (Wash.)78, 4591, 1981.
Dippold W. G., Lloyd K. O., Li L. T. L., Ikeda H., Oettgen H. F., Old L. J.: Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies — Proc. nat. Acad. Sci. (Wash.)77, 6114, 1980.
Fazekas de St. Groth S., Scheidegger D.: Production of monoclonal antibodies: strategy and tactics — J. immunol. Meth.35, 1, 1980.
Ferrone S., Pellegrino M. A.: Antigens and antibodies in malignant melanoma. In:Waters H. (Ed.): Handbook of cancer immunology. Garland STPM Press, New York, 1978; p. 291.
Ferrone S., Pellegrino M. A.: Serological detection of human melanoma associated antigens. In:Herberman R. B., McIntire K. R. (Eds): Immunodiagnosis of cancer. Marcel Dekker, New York, 1979; p. 588.
Galloway D. R., McCabe R. P., Pellegrino M. A., Ferrone S., Reisfeld R. A.: Tumor-associated antigens in the spent media of human melanoma cells: immunochemical characterization with xenoantisera — J. Immunol.126, 62, 1981.
Glassy M. C., Pellegrino M. A., Quaranta V., Molinaro G. A., Ferrone S.: Lack of DR antigens on human B lymphocyte-mouse fibroblast hybrids that express HLA-A,B antigens — Transplant. Proc.11, 1719, 1979.
Goding J. W.: Antibody production by hybridoma — J. immunol. Meth.39, 285, 1980.
Hellstrom I., Hellstrom K. E., Yeh M.: Lymphocyte-dependent antibodies to antigens 3.1, a cell-surface antigen expressed by a subgroup of human melanomas — Int. J. Cancer27, 281, 1981.
Hellstrom K. E., Hellstrom I.: Lymphocyte mediated cytotoxicity and blocking serum activity to tumor antigens — Advanc. Immunol.18, 209, 1974.
Herlyn M., Clark W. H., Mastrangelo M. J., Guerry N. D., Elder D. E., La Russa D., Hamilton R., Bondi E., Tuthill R., Steplewski Z., Koprowski H.: Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells — Cancer Res.40, 3602, 1980.
Herlyn M., Steplewski Z., Herlyn D., Koprowski H.: Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies — Proc. nat. Acad. Sci. (Wash.)76, 1438, 1979.
Houghton A. N., Oettgen H. F., Old L. J.: Malignant melanoma: current status of the search for melanoma-specific antigens. In:Safai B., Good R. A. (Eds): Immunodermatology. Plenum Press, New York, 1981; p. 557.
Imai K., Galloway D. R., Ferrone S.: Serological and immunochemical analysis of the specificity of the xenoantiserum 8986 elicited with hybrids between human melanoma and murine fibroblasts — Cancer Res.41, 1028, 1981.
Imai K., Natali P. G., Kay N. E., Wilson B. S., Ferrone S.: Tissue distribution and molecular profile of a differentiation antigen detected by a monoclonal antibody (345.134S) produced against human melanoma cells — Cancer Immunol. Immunother.12, 159, 1982.
Imai K., Ng A. K., Ferrone S.: Characterization of monoclonal antibodies to human melanoma-associated antigens — J. nat. Cancer Inst.66, 489, 1981.
Imai K., Ng A. K., Glassy M. C., Ferrone S.: Differential effect of interferon on the expression of tumor associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies — J. Immunol.127, 505, 1981.
Imai K., Ng A. K., Glassy M. C., Ferrone S.: ADCC of cultured human melanoma cells: analysis with monoclonal antibodies to human melanoma-associated antigens — Scand. J. Immunol.14, 369, 1981.
Imai K., Wilson B. S., Bigotti A., Natali P. G., Ferrone S.: A 94,000 dalton glycoprotein expressed by human melanoma and carcinoma cells — J. nat. Cancer Inst. 1982. (In press).
Imai K., Wilson B. S., Kay N. E., Ferrone S.: Comparison of the serological results of several laboratories and molecular profile of melanoma-associated antigens. In:Hammerling G. J., Hammerling U., Kearney J. F. (Eds): Monoclonal antibodies and T cell hybrids. Elsevier Publ. Co., Amsterdam, 1981; p. 183.
Imai K., Yachi A., Ng A. K., Ferrone S.: Antigen expression and immune lysis of human tumor cells: analysis with monoclonal antibodies. In:Peeters H. H. (Ed.): Protides of the biological fluids. 29th Colloquium, 1981. Pergamon Press, Oxford, 1982; p. 883.
Johnson J., Demmer Dieckman M., Meo T., Adam M. R., Reithmüller G.: Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin — Europ. J. Immunol.11, 825, 1981.
Kohler G., Milstein C.: Continuous cultures of fused cells secreting antibody of predefined specificity — Nature (Lond.)256, 495, 1975.
Krim M.: Towards tumor therapy with interferon. Part II. Interferon:in vivo effects Blood55, 875, 1980.
Kupchik H. Z., Zurawski V. R. Jr.,Hurrell J. G. R., Zamcheck N., Black P. H.: Monoclonal antibodies to carcinoembryonic antigen produced by somatic cell fusion — Cancer Res.41, 3306, 1981.
Liao S. K., Clarke B. J., Kwang P. C., Brickenden A., Gallie B., Dent P. B.: Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells — Europ. J. Immunol.11, 45, 1981.
Liao S. K., Kwang P. C., Khosravi M., Dent P. B.: Enhanced expression of melanoma associated antigens and β2-microglobulin on cultured human melanoma cells by interferon — J. nat. Cancer Inst.68, 19, 1981.
Loop S. M., Nishiyama K., Hellstrom I., Woodbury R. G., Brown J. P., Hellstrom K. E.: Two human tumor-associated antigens, p155 and p210, detected by monoclonal antibodies — Int. J. Cancer27, 775, 1981.
Martin W. J., Inamura M.: Variable expression of histocompatibility antigens on tumor cells — Cancer Immunol. Immunother.8, 219, 1980.
Mastrangelo M., Bellit R. E., Berd D.: Immunology and immunotherapy of human cutaneous malignant melanoma. In:Clark W. H. Jr.,Mastrangelo M., Goldman L. I. (Eds): Human malignant melanoma. Grune and Stratton, New York, 1979; p. 355.
Mitchell K. F., Fuhrer J. P., Steplewski Z., Koprowski H.: Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies — Proc. nat. Acad. Sci. (Wash.)77, 7287, 1980.
Nakanishi T., Yoshizumi H., Tahara S., Hakura A., Toyshima K.: Cytotoxicity of Purothionin-H on various animal cells — Gann70, 323, 1979.
Natali P. G., Imai K., Wilson B. S., Bigotti A., Cavaliere R., Pellegrino M. A., Ferrone S.: Structural properties and tissue distribution of the antigens recognized by the monoclonal antibody 653.40S to human melanoma cells — J. nat. Cancer Inst.67, 591, 1981.
Natali P. G., Wilson B. S., Imai K., Bigotti A., Ferrone S.: Tissue distribution, molecular profile and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.125 to human melanoma cells — Cancer Res.42, 583, 1982.
Quaranta V., Imai K., Molinaro G. A., Ferrone S.: Manufacture of monoclonal antibodies to human melanoma associated antigens and histocompatibility antigens. In:Nakamura R. M., Dito W. R., Tucker E. S. III (Eds): Immunoassays: clinical laboratory techniques for the 1980s. A. R. Liss, Inc., New York, 1980; p. 301.
Quaranta V., Pellegrino M. A., Ferrone S.: Serological and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens — J. Immunol.126, 548, 1981.
Russo C., Pellegrino M. A., Ng A. K., Wilson B. S., Ferrone S.: Antigenic constitution of HLA-A,B,C molecules: immunochemical analysis with monoclonal antibodies. In:Ferrone S., Solheim B. (Eds): HLA typing: methodology and clinical aspects. CRC Press, Boca Raton, 1982; p. 77.
Schnegg J. F., Diserans A. C., Carrel S., Accolla R. S., DeTribolet N.: Human glioma-associated antigens detected by monoclonal antibodies — Cancer Res.41, 1209, 1981.
Sobol R. E., Dillman R. O., Smith J. D., Imai K., Ferrone S., Shawler D., Glassy M. C., Royston I.: Phase I evaluation of murine monoclonal anti-melanoma antibody in man: preliminary observations. In:Mitchell M., Oettgen H. (Eds): Hybridoma in cancer diagnosis and treatment. Raven Press, New York, 1982; p. 199.
Stuhlmiller G. M., Green R. W., Siegler H. F.: Solubilization and partial isolation of human melanoma tumor-associated antigens — J. nat. Cancer Inst.61, 61, 1978.
Wilson B. S., Imai K., Natali P. G., Cavaliere R., Pellegrino M. A., Ferrone S.: Antigenic profile of human melanoma cells: analysis with monoclonal antibodies. In:Reisfeld R. A., Ferrone S. (Eds): Melanoma antigens and antibodies. Plenum Press, New York. (In press).
Wilson B. S., Imai K., Natali P. G., Ferrone S.: Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies — Int. J. Cancer28, 293, 1981.
Woodbury R. G., Brown J. P., Loop S. M., Hellstrom K. E., Hellstrom I.: Analysis of normal neoplastic human tissues for the tumor-associated protein p97 — Int. J. Cancer27, 145, 1981.
Woodbury R. G., Brown J. P., Yeh M.-Y., Hellstrom I., Hellstrom K. E.: Identification of a cell surface protein p97 in human melanoma and certain other neoplasms — Proc. nat. Acad. Sci. (Wash.)77, 2183, 1980.
Author information
Authors and Affiliations
Additional information
This work was supported by the National Institutes of Health, grants AI 19189, CA 32609, CA 32619, CA 32634, CA 32635, a special fellowship from the Leukemia Association of America (B. S. Wilson) and a fellowship fromAssociazione Italiana per la Ricerca sul Cancro (AIRC) (P. Giacomini). P. G. Natali was supported byConsiglio Nazionale delle Ricerche (CNR), Roma, Italy, ‘Progetto Finalizzato Controllo della Crescita Neoplastica’, grant no. 80.01599.96.
Rights and permissions
About this article
Cite this article
Wilson, B.S., Giacomini, P., Imai, K. et al. Human melanoma-associated antigens identified with monoclonal antibodies. La Ricerca Clin. Lab. 12, 517–538 (1982). https://doi.org/10.1007/BF02909339
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02909339